Table 2.

Ranking table of cumulative probabilities.

Outcome indicators	A	AC	B	BC	C	DC	E	EC	F	FC
Qmax	0.2414264	0.5479111	0.1066944	0.5032847	0.1418361	0.9057833	0.5084375	0.6705097	0.6018458	0.7722708
MCC	0.26220556	0.96212639	0.21929028	0.05569861	0.25687083	0.63666389	0.90227778	0.50460833	0.70055000	0.49970833
PVR	0.3359486	0.7682708	0.1408194	0.4453556	0.2126347	0.9004861	0.3646000	0.8170264	0.6073319	0.4075264
MVV	0.276897222	0.483001389	0.00579444	0.20909722	0.292456944	0.690930556	0.510359722	0.886373611	0.780005556	0.865083333
24 h Voiding Freq	0.36750694	0.66641944	0.06395139	0.09934444	0.33403194	0.89506806	0.79202778	0.44338194	0.88583194	0.45243611
24 h UI Episodes	0.59594375	0.59267188	0.03877031	0.34196719	0.23366250	0.91051563	0.41582969	0.58232656	0.78831250	-

“–” Indicates that the intervention was excluded from this outcome measure. Each value represents the cumulative probability of the corresponding intervention for a specific outcome measure. Qmax, Maximum urinary flow rate; MCC, Maximum cystometric capacity; PVR, Post-void residual volume; MVV, Mean voided volume; 24 h Voiding Freq, 24-h voiding frequency; 24 h UI Episodes, 24-h urinary incontinence episodes; A, Sacral neuromodulation; AC, Sacral neuromodulation combined with conventional therapy; B, Placebo; BC, Placebo combined with conventional therapy; C, Conventional therapy; DC, Neuromuscular electrical stimulation combined with conventional therapy; E, Tibial nerve stimulation; EC, Tibial nerve stimulation combined with conventional therapy; F, Transcutaneous electrical nerve stimulation; FC, Transcutaneous electrical nerve stimulation combined with conventional therapy.